I. E. Eryilmaz Et Al. , "An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.," Clinical and experimental pharmacology & physiology , vol.49, no.10, pp.1094-1104, 2022
Eryilmaz, I. E. Et Al. 2022. An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.. Clinical and experimental pharmacology & physiology , vol.49, no.10 , 1094-1104.
Eryilmaz, I. E., Egeli, Ü., & Cecener, G., (2022). An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.. Clinical and experimental pharmacology & physiology , vol.49, no.10, 1094-1104.
Eryilmaz, IŞIL, ÜNAL EGELİ, And GÜLŞAH ÇEÇENER. "An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.," Clinical and experimental pharmacology & physiology , vol.49, no.10, 1094-1104, 2022
Eryilmaz, IŞIL E. Et Al. "An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.." Clinical and experimental pharmacology & physiology , vol.49, no.10, pp.1094-1104, 2022
Eryilmaz, I. E. Egeli, Ü. And Cecener, G. (2022) . "An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.." Clinical and experimental pharmacology & physiology , vol.49, no.10, pp.1094-1104.
@article{article, author={IŞIL EZGİ ERYILMAZ Et Al. }, title={An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.}, journal={Clinical and experimental pharmacology & physiology}, year=2022, pages={1094-1104} }